sixteen patients ( 5.3 % ) developed recurrent cancer in the treated breast beyond the tenth year , the actuarial probability of remaining free of breast recurrence being 94 % and 90 % at 15 and 20 years , respectively .
C0278493
recurrent cancer
C0006141
breast